Trager, Megan H.
Rizk, Emanuelle
Rose, Sharon
Zhu, Kuixi
Lau, Branden
Fullerton, Benjamin T.
Pradhan, Jaya
Moore, Michael
Srivastava, Ayush C.
Singer, Giselle
Gartrell, Robyn
Chang, Rui
Geskin, Larisa J.
Saenger, Yvonne M.
Goldenberg, Gary
Funding for this research was provided by:
Valeant Pharmaceuticals International
Article History
Received: 29 December 2020
Accepted: 8 April 2021
First Online: 22 April 2021
Competing interests
: Yvonne Saenger receives funding from Amgen and Regeneron and has equity in a small biomarker start-up company, Wasaba. The remaining authors have no relevant conflicts of interest to disclose.